Partner
David Hardwicke
Investment Consultant, Pathway Bioventures
- Firm
- Pathway Bioventures
- Title
- Investment Consultant
- Role
- Employee
Claim, correct or request removal
Record updated 18 September 2026
About
David is a biotechnology professional with a background in technology commercialization, program management, and drug development with prior positions at Novartis Gene Therapies and NK-cell therapy developer ONK Therapeutics. As a consultant with Pathway Bioventures, David works on new investment opportunities and has contributed to our investments in gene editing, RNA therapeutics, and novel cancer therapies.
Is this you? Remove my profile
Loading relationship preview